| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | Chief Medical Officer | Restricted Stock Unit | 57,505 | $5,985,695 | $104.09 | 10 Mar 2025 | Direct |
| Arcus Biosciences, Inc. | Director | Common Stock | 0 | $0 | $15.00 | 06 Feb 2025 | Direct |
| GILEAD SCIENCES, INC. | Chief Medical Officer | Non-qualified Stock Option (Right to Buy) | 37,710 | 10 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GILD | GILEAD SCIENCES, INC. | 10 Mar 2025 | 2 | $0 | 4 | Chief Medical Officer | 12 Mar 2025, 18:04 |
| RCUS | Arcus Biosciences, Inc. | 06 Feb 2025 | 0 | $0 | 3 | Director | 10 Feb 2025, 17:15 |
| GILD | GILEAD SCIENCES, INC. | 02 Jan 2025 | 1 | $0 | 4 | Chief Medical Officer | 03 Jan 2025, 18:38 |
| GILD | GILEAD SCIENCES, INC. | 02 Jan 2025 | 0 | $0 | 3 | Chief Medical Officer | 03 Jan 2025, 18:33 |